dc.date.accessioned | 2018-02-21T17:45:25Z | |
dc.date.available | 2018-02-21T17:45:25Z | |
dc.date.issued | 2016-11-15 | |
dc.identifier | pat9492523 | |
dc.identifier.uri | https://hdl.handle.net/11244/54434 | |
dc.description.abstract | Broad-based, cross-protective, O-serotype independent vaccines against Shigella and related pathogenic organisms are provided. The vaccines comprise one or more of the type III secretion (TTS) apparatus needle proteins IpaD and IpaB, and/or the IpaB cognate chaperone protein IpgC. Chimeric proteins of IpaD and IpaB, and/or IpgC are also encompassed. | |
dc.format | application/pdf | |
dc.format.extent | 61 pages | |
dc.language | en_US | |
dc.publisher | U.S. Patent and Trademark Office | |
dc.title | Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins | |
dc.type | text | |
osu.filename | pat9492523.pdf | |
osu.accesstype | Open Access | |
dc.type.genre | Patent | |
dc.contributor.inventor | Picking, Wendy L. | |
dc.contributor.inventor | Picking, William D. | |
dc.identifier.patentID | 9,492,523 | |
dc.date.filed | 2012-12-10 | |
dc.contributor.assignee | Board of Regents/Oklahoma State University and the A & M Colleges | |
dc.subject.cpcclasses | A61K 39/0283 (20130101) | |
dc.subject.cpcclasses | C07K 14/25 (20130101) | |
dc.subject.cpcclasses | A61K 2039/543 (20130101) | |
dc.subject.cpcclasses | A61K 2039/55544 (20130101) | |
dc.subject.cpcclasses | A61K 2039/58 (20130101) | |
dc.subject.cpcclasses | A61K 2039/54 (20130101) | |